MP79-04 THE PRECLINICAL CHARACTERIZATION AND DEVELOPMENT OF EPI-7386, AN N-TERMINAL DOMAIN ANDROGEN RECEPTOR INHIBITOR, FOR THE TREATMENT OF PROSTATE CANCER | Zendy

AI Assistant Blog Pricing

MP79-04 THE PRECLINICAL CHARACTERIZATION AND DEVELOPMENT OF EPI-7386, AN N-TERMINAL DOMAIN ANDROGEN RECEPTOR INHIBITOR, FOR THE TREATMENT OF PROSTATE CANCER

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.